
    
      A double-blind, placebo-controlled, single-center, randomized study to assess the safety and
      preliminary efficacy of a three serial intravenous doses of allogeneic mesenchymal bone
      marrow cells to subjects with heart failure and implanted left ventricular assist devices.
    
  